Categories: News

Change in the Board of Directors of NTG Nordic Transport Group A/S

Company announcement no. 19 21
6 August 2021

Change in the Board of Directors of NTG Nordic Transport Group A/S

Member of the Board of Directors and Chairman of the Audit Committee, Ulrik Ross, has informed the Board of Directors that he will step down from the Board of Directors with effect as of 31 August 2021.

The Board of Directors would like to thank Ulrik Ross for his work and valuable contributions as a member of the Board of Directors of NTG since 2018.

Following the change, the Board of Directors of NTG will consist of:

Eivind Kolding, Chairman
Jørgen Hansen, Vice Chairman
Carsten Krogsgaard Thomsen, Member of the Board of Directors
Karen-Marie Katholm, Member of the Board of Directors
Finn Skovbo Pedersen, Member of the Board of Directors
Jesper Præstensgaard, Member of the Board of Directors

Additional information

For additional information, please contact:

Eivind Kolding, Chairman of the Board of Directors        +45 23 61 73 25

Attachment

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

8 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

11 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

11 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

11 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

11 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

11 hours ago